311
Views
4
CrossRef citations to date
0
Altmetric
Articles

Borderline Features and Prescription Opioid Misuse in a Substance Use Disorder Treatment Sample

&
Pages 166-175 | Received 17 Oct 2017, Accepted 12 Aug 2018, Published online: 30 Oct 2018

References

  • Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010). Borderline personality disorder: A dysregulation of the endogenous opioid system? Psychological Review, 117(2), 623.
  • Bender, D. S., Dolan, R. T., Skodol, A. E., Sanislow, C. A., Dyck, I. R., McGlashan, T. H., … Gunderson, J. G. (2001). Treatment utilization by patients with personality disorders. American Journal of Psychiatry, 158(2), 295–302.
  • Campbell, G., Bruno, R., Darke, S., & Degenhardt, L. (2015). Associations of borderline personality with pain, problems with medications and suicidality in a community sample of chronic non-cancer pain patients prescribed opioids for pain. General Hospital Psychiatry, 37(5), 434–440. doi:10.1016/j.genhosppsych.2015.05.004
  • Chen, L. H., Hedegaard, H., & Warner, M. (2014). Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS Data Brief, 166, 1–8.
  • Darke, S., Ross, J., Williamson, A., & Teesson, M. (2005). The impact of borderline personality disorder on 12‐month outcomes for the treatment of heroin dependence. Addiction, 100(8), 1121–1130.
  • Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241–248. doi: doi:10.1056/NEJMsa1406143
  • Eisenberger, N. I., & Lieberman, M. D. (2004). Why rejection hurts: A common neural alarm system for physical and social pain. Trends in Cognitive Sciences, 8(7), 294–300.
  • Frankenburg, F. R., Fitzmaurice, G. M., & Zanarini, M. C. (2014). The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: A 10-year follow-up study. The Journal of Clinical Psychiatry, 75(4), 357.
  • Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., … Ruan, W. J. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 69(4), 533.
  • Hopwood, C. J., Baker, K. L., & Morey, L. C. (2008). Extratest validity of selected personality assessment inventory scales and indicators in an inpatient substance abuse setting. Journal of Personality Assessment, 90(6), 574–577.
  • IBM Corp. (2016). IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.
  • Jan, S. A. (2010). Landscape of opioid dependence. Journal of Managed Care & Pharmacy, 16(1-b), S4–S8.
  • Kross, E., Berman, M. G., Mischel, W., Smith, E. E., & Wager, T. D. (2011). Social rejection shares somatosensory representations with physical pain. Proceedings of the National Academy of Sciences, 108(15), 6270–6275.
  • Langås, A. M., Malt, U. F., & Opjordsmoen, S. (2012). In-depth study of personality disorders in first-admission patients with substance use disorders. BMC Psychiatry, 12, 180.
  • Magyar, M. S., Edens, J. F., Lilienfeld, S. O., Douglas, K. S., Poythress, N. G., Jr., & Skeem, J. L. (2012). Using the Personality Assessment Inventory to predict male offenders' conduct during and progression through substance abuse treatment. Psychological Assessment, 24(1), 216.
  • Morey, L. C. (1991). Personality assessment inventory: Professional manual. Odessa, FL: Psychological Assessment Resources.
  • Muthén, L., & Muthén, B. (2015). Mplus (7th ed.). Los Angeles, CA: Muthén & Muthén.
  • Prossin, A. R., Love, T. M., Koeppe, R. A., Zubieta, J. K., & Silk, K. R. (2010). Dysregulation of regional endogenous opioid function in borderline personality disorder. American Journal of Psychiatry, 167(8), 925–933.
  • Sansone, R. A., & Wiederman, M. W. (2009). The abuse of prescription medications: Borderline personality patients in psychiatric versus non-psychiatric settings. The International Journal of Psychiatry in Medicine, 39(2), 147–154.
  • Sher, K. J., Trull, T. J., Bartholow, B. D., & Vieth, A. (1999). Personality and alcoholism: Issues, methods, and etiological processes. In K. E. Leonard & H. T. Blane (Eds.), Psychological theories of drinking and alcoholism (pp. 54–105). New York, NY: Guilford Press.
  • Smith, P. H., Homish, G. G., Leonard, K. E., & Cornelius, J. R. (2012). Intimate partner violence and specific substance use disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychology of Addictive Behaviors, 26(2), 236.
  • Stanley, B., Sher, L., Wilson, S., Ekman, R., Huang, Y. Y., & Mann, J. J. (2010). Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. Journal of Affective Disorders, 124(1–2), 134–140.
  • Stanley, B., & Siever, L. J. (2010). The interpersonal dimension of borderline personality disorder: Toward a neuropeptide model. American Journal of Psychiatry, 167(1), 24–39.
  • Stein, M. B., Pinsker-Aspen, J. H., & Hilsenroth, M. J. (2007). Borderline pathology and the Personality Assessment Inventory (PAI): An evaluation of criterion and concurrent validity. Journal of Personality Assessment, 88(1), 81–89.
  • Substance Abuse and Mental Health Services Administration [SAMHSA]. (2010). 2010 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • Thompson, C. G., Kim, R. S., Aloe, A. M., & Becker, B. J. (2017). Extracting the variance inflation factor and other multicollinearity diagnostics from typical regression results. Basic and Applied Social Psychology, 39(2), 81–90.
  • Tragesser, S. L., Bruns, D., & Disorbio, J. M. (2010). Borderline personality disorder features and pain: The mediating role of negative affect in a pain patient sample. The Clinical Journal of Pain, 26(4), 348–353.
  • Tragesser, S. L., Jones, R. E., Robinson, R. J., Stutler, A., & Stewart, A. (2013). Borderline personality disorder features and risk for prescription opioid use disorders. Journal of Personality Disorders, 27(4), 427–441.
  • Trigo, J. M., Martin-García, E., Berrendero, F., Robledo, P., & Maldonado, R. (2010). The endogenous opioid system: A common substrate in drug addiction. Drug and Alcohol Dependence, 108(3), 183–194.
  • Trull, T. J., Sher, K. J., Minks-Brown, C., Durbin, J., & Burr, R. (2000). Borderline personality disorder and substance use disorders: A review and integration. Clinical Psychology Review, 20(2), 235–253.
  • Vest, N., Reynolds, C. J., & Tragesser, S. L. (2016). Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample. Addictive Behaviors, 60, 184–190.
  • Watkins, K. E., Hunter, S. B., Wenzel, S. L., Tu, W., Paddock, S. M., Griffin, A., & Ebener, P. (2004). Prevalence and characteristics of clients with co‐occurring disorders in outpatient substance abuse treatment. The American Journal of Drug and Alcohol Abuse, 30(4), 749–764.
  • Zikos, E., Gill, K. J., & Charney, D. A. (2010). Personality disorders among alcoholic outpatients: prevalence and course in treatment. The Canadian Journal of Psychiatry, 55(2), 65–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.